Hugh Jones

685 total citations
19 papers, 501 citations indexed

About

Hugh Jones is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hugh Jones has authored 19 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 10 papers in Cognitive Neuroscience and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hugh Jones's work include Schizophrenia research and treatment (14 papers), Functional Brain Connectivity Studies (6 papers) and Electroconvulsive Therapy Studies (5 papers). Hugh Jones is often cited by papers focused on Schizophrenia research and treatment (14 papers), Functional Brain Connectivity Studies (6 papers) and Electroconvulsive Therapy Studies (5 papers). Hugh Jones collaborates with scholars based in United Kingdom, Poland and Ireland. Hugh Jones's co-authors include Lyn S. Pilowsky, Rodrigo A. Bressan, Anthony S. David, Gildas Brébion, Peter J. Ell, Rachel S. Mulligan, Kjell Erlandsson, Ruth Ohlsen, Durval C. Costa and Robert J. Flanagan and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Hugh Jones

18 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugh Jones United Kingdom 13 367 192 108 67 52 19 501
Sanne Wulff Denmark 9 347 0.9× 267 1.4× 120 1.1× 61 0.9× 46 0.9× 10 489
M. L. Paillère-Martinot France 8 415 1.1× 207 1.1× 172 1.6× 32 0.5× 86 1.7× 10 613
Kristan Armstrong United States 13 223 0.6× 264 1.4× 104 1.0× 72 1.1× 21 0.4× 33 479
Grant McQueen United Kingdom 12 222 0.6× 149 0.8× 82 0.8× 47 0.7× 38 0.7× 24 473
F Barouche United States 10 316 0.9× 127 0.7× 122 1.1× 106 1.6× 175 3.4× 14 528
JoAnn Goodson United States 7 180 0.5× 120 0.6× 72 0.7× 87 1.3× 31 0.6× 13 328
Francesca Bolino Italy 10 247 0.7× 182 0.9× 152 1.4× 100 1.5× 129 2.5× 15 523
David L. Garver United States 9 250 0.7× 113 0.6× 82 0.8× 50 0.7× 18 0.3× 12 401
Concetta Petruzzi Italy 14 251 0.7× 131 0.7× 51 0.5× 40 0.6× 50 1.0× 23 565
Shawn L. Cassady United States 13 306 0.8× 190 1.0× 57 0.5× 54 0.8× 23 0.4× 18 479

Countries citing papers authored by Hugh Jones

Since Specialization
Citations

This map shows the geographic impact of Hugh Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Jones more than expected).

Fields of papers citing papers by Hugh Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Jones. The network helps show where Hugh Jones may publish in the future.

Co-authorship network of co-authors of Hugh Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Jones. A scholar is included among the top collaborators of Hugh Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Jones. Hugh Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Brébion, Gildas, Anthony S. David, Hugh Jones, & Lyn S. Pilowsky. (2009). Working Memory Span and Motor and Cognitive Speed in Schizophrenia. Cognitive and Behavioral Neurology. 22(2). 101–108. 17 indexed citations
2.
Brébion, Gildas, Anthony S. David, Ruth Ohlsen, Hugh Jones, & Lyn S. Pilowsky. (2007). Visual memory errors in schizophrenic patients with auditory and visual hallucinations. Journal of the International Neuropsychological Society. 13(5). 832–838. 21 indexed citations
3.
Brébion, Gildas, Anthony S. David, Hugh Jones, Ruth Ohlsen, & Lyn S. Pilowsky. (2006). Temporal context discrimination in patients with schizophrenia: Associations with auditory hallucinations and negative symptoms. Neuropsychologia. 45(4). 817–823. 31 indexed citations
4.
Brébion, Gildas, Anthony S. David, Hugh Jones, & Lyn S. Pilowsky. (2005). Hallucinations, Negative Symptoms, and Response Bias in a Verbal Recognition Task in Schizophrenia.. Neuropsychology. 19(5). 612–617. 34 indexed citations
5.
Jones, Hugh, Michael Brammer, Ruth Ohlsen, et al.. (2004). Cortical effects of quetiapine in first-episode schizophrenia: A preliminary functional magnetic resonance imaging study. Biological Psychiatry. 56(12). 938–942. 33 indexed citations
6.
Ohlsen, Ruth, et al.. (2004). Clinical effectiveness in first-episode patients. European Neuropsychopharmacology. 14. S445–S451. 21 indexed citations
7.
Brébion, Gildas, Anthony S. David, Lyn S. Pilowsky, & Hugh Jones. (2004). Recognition of Visual Stimuli and Memory for Spatial Context in Schizophrenic Patients and Healthy Volunteers. Journal of Clinical and Experimental Neuropsychology. 26(8). 1093–1102. 12 indexed citations
8.
Bressan, Rodrigo A., Hugh Jones, & Lyn S. Pilowsky. (2004). Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity. Journal of Psychopharmacology. 18(1). 124–127. 20 indexed citations
9.
Brébion, Gildas, Anthony S. David, Hugh Jones, & Lyn S. Pilowsky. (2004). Semantic Organization and Verbal Memory Efficiency in Patients With Schizophrenia.. Neuropsychology. 18(2). 378–383. 63 indexed citations
10.
Bressan, Rodrigo A., Kjell Erlandsson, Hugh Jones, et al.. (2003). Optimizing Limbic Selective D2/D3 Receptor Occupancy by Risperidone: A [123I]-Epidepride SPET Study. Journal of Clinical Psychopharmacology. 23(1). 5–14. 51 indexed citations
11.
Bressan, Rodrigo A., Kjell Erlandsson, Hugh Jones, et al.. (2003). Is Regionally Selective D2/D3 Dopamine Occupancy Sufficient for Atypical Antipsychotic Effect? An In Vivo Quantitative [123I]Epidepride SPET Study of Amisulpride-Treated Patients. American Journal of Psychiatry. 160(8). 1413–1420. 83 indexed citations
12.
Jones, Hugh, Vivienne Curtis, Pádraig Wright, Lyn S. Pilowsky, & James V. Lucey. (2002). d-Fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients. Psychiatry Research. 113(1-2). 41–47. 2 indexed citations
13.
Bressan, Rodrigo A., Durval C. Costa, Hugh Jones, Peter J. Ell, & Lyn S. Pilowsky. (2002). Typical antipsychotic drugs — D2 receptor occupancy and depressive symptoms in schizophrenia. Schizophrenia Research. 56(1-2). 31–36. 64 indexed citations
14.
Jones, Hugh & Lyn S. Pilowsky. (2002). New targets for antipsychotics. Expert Review of Neurotherapeutics. 2(1). 61–68. 5 indexed citations
15.
Jones, Hugh, Michael J. Travis, Rachel S. Mulligan, et al.. (2001). In vivo 5-HT 2A receptor blockade by quetiapine. Psychopharmacology. 157(1). 60–66. 27 indexed citations
16.
Jones, Hugh, et al.. (1998). Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophrenia. International Clinical Psychopharmacology. 13(5). 199–204. 4 indexed citations
17.
Jones, Hugh, Vivienne Curtis, Pádraig Wright, & James V. Lucey. (1998). Neuroendocrine Evidence That Clozapine's Serotonergic Antagonism Is Relevant to Its Efficacy in Treating Hallucinations and Other Positive Schizophrenic Symptoms. American Journal of Psychiatry. 155(6). 838–840. 9 indexed citations
18.
Jones, Hugh, Rachel Jones, & James V. Lucey. (1998). Review of College guidelines on high-dose neuroleptic use in a psychiatric intensive care unit. Psychiatric Bulletin. 22(10). 598–600. 3 indexed citations
19.
Bass, Christopher, et al.. (1987). DEATH ASSOCIATED WITH HYPERVENTILATION. The Lancet. 329(8538). 925–925. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanne Wulff Breakdown of academic impact, for papers by M. L. Paillère-Martinot Breakdown of academic impact, for papers by Kristan Armstrong Breakdown of academic impact, for papers by Grant McQueen Breakdown of academic impact, for papers by F Barouche Breakdown of academic impact, for papers by JoAnn Goodson Breakdown of academic impact, for papers by Francesca Bolino Breakdown of academic impact, for papers by David L. Garver Breakdown of academic impact, for papers by Concetta Petruzzi Breakdown of academic impact, for papers by Shawn L. Cassady
Rankless by CCL
2026